CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
CIGB-370 in patients with malignant tumors	01/02/2016	Registered
AVATAR-2020	01/03/2021	Registered outdated
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents	01/07/2021	Registered
OLIVO Study	01/10/2020	Registered
Pharmacodynamics of the Nasalferon in healthy volunteers.	03/05/2020	Registered
HeberNasvac® Phase IV in Chronic Hepatitis B	03/08/2018	Registered outdated
MEÑIQUE Study	03/09/2021	Registered
HEBERFERON in renal cell carcinoma	05/01/2017	Registered outdated
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock	06/07/2023	Registered
Transfer factor in Chronic Kidney Disease	06/08/2020	Registered outdated
Nasal recombinant human interferon alfa-2b in ARI	06/12/2022	Registered
AMIGOS-2 study	07/08/2018	Registered outdated
CERVICONC-II-300 study	07/08/2018	Registered outdated
THERESA-5 Study	08/04/2015	Registered
CIGB-Mambisa/Abdala in convalescents	09/07/2021	Registered outdated
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized.	10/11/2014	Registered
Expanded Clinical Use of Nasalferon in COVID-19	10/11/2021	Registered outdated
CIGB2020- ARI elderly contacts	11/03/2021	Registered outdated
DALIA Study	11/08/2020	Registered outdated
BACONAO Study	12/11/2021	Registered outdated